Cayman Islands | 001-34775 | 98-1228572 | ||||||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
Title of each class | Trading Symbol(s) |
Name of each exchange on which registered |
||||||||||||
Ordinary Shares, $0.01 par value | FN | New York Stock Exchange |
Exhibit No. | Description | |||||||
99.1 | ||||||||
104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
FABRINET | ||||||||
By: | /s/ CSABA SVERHA | |||||||
Csaba Sverha | ||||||||
Executive Vice President, Chief Financial Officer | ||||||||
Date: November 6, 2023 |
What: | Fabrinet First Quarter Fiscal Year 2024 Financial Results Call |
|||||||
When: | November 6, 2023 |
|||||||
Time: | 5:00 p.m. ET | |||||||
Live Call and Replay: | https://investor.fabrinet.com/events-and-presentations/events |
(in thousands of U.S. dollars, except share data and par value) | September 29, 2023 |
June 30, 2023 |
|||||||||
Assets | |||||||||||
Current assets | |||||||||||
Cash and cash equivalents | $ | 308,338 | $ | 231,368 | |||||||
Short-term investments | 362,428 | 319,100 | |||||||||
Trade accounts receivable, net of allowance for doubtful accounts of $1,768 and $965, respectively |
535,006 | 531,767 | |||||||||
Inventories | 440,095 | 519,576 | |||||||||
Prepaid expenses | 6,328 | 7,849 | |||||||||
Other current assets | 39,766 | 42,880 | |||||||||
Total current assets | 1,691,961 | 1,652,540 | |||||||||
Non-current assets | |||||||||||
Property, plant and equipment, net | 306,665 | 310,350 | |||||||||
Intangibles, net | 2,598 | 2,394 | |||||||||
Operating right-of-use assets | 6,024 | 1,634 | |||||||||
Deferred tax assets | 11,363 | 12,095 | |||||||||
Other non-current assets | 610 | 635 | |||||||||
Total non-current assets | 327,260 | 327,108 | |||||||||
Total Assets | $ | 2,019,221 | $ | 1,979,648 | |||||||
Liabilities and Shareholders’ Equity | |||||||||||
Current liabilities | |||||||||||
Long-term borrowings, current portion, net | $ | 9,117 | $ | 12,156 | |||||||
Trade accounts payable | 357,106 | 381,129 | |||||||||
Fixed assets payable | 9,313 | 13,526 | |||||||||
Operating lease liabilities, current portion | 1,587 | 1,201 | |||||||||
Income tax payable | 7,013 | 6,024 | |||||||||
Accrued payroll, bonus and related expenses | 22,976 | 23,748 | |||||||||
Accrued expenses | 24,034 | 20,447 | |||||||||
Other payables | 24,287 | 23,654 | |||||||||
Total current liabilities | 455,433 | 481,885 | |||||||||
Non-current liabilities | |||||||||||
Deferred tax liability | 5,117 | 4,799 | |||||||||
Operating lease liability, non-current portion | 4,052 | 66 | |||||||||
Severance liabilities | 22,269 | 22,159 | |||||||||
Other non-current liabilities | 2,181 | 2,081 | |||||||||
Total non-current liabilities | 33,619 | 29,105 | |||||||||
Total Liabilities | 489,052 | 510,990 | |||||||||
Shareholders’ equity | |||||||||||
Preferred shares (5,000,000 shares authorized, $0.01 par value; no shares issued and outstanding as of September 29, 2023 and June 30, 2023) |
— | — | |||||||||
Ordinary shares (500,000,000 shares authorized, $0.01 par value; 39,430,970 shares and 39,284,176 shares issued at September 29, 2023 and June 30, 2023, respectively; and 36,330,476 shares and 36,183,682 shares outstanding at September 29, 2023 and June 30, 2023, respectively) |
394 | 393 | |||||||||
Additional paid-in capital | 202,432 | 206,624 | |||||||||
Less: Treasury shares (3,100,494 shares as of September 29, 2023 and June 30, 2023) |
(194,833) | (194,833) | |||||||||
Accumulated other comprehensive income (loss) | (7,502) | (8,115) | |||||||||
Retained earnings | 1,529,678 | 1,464,589 | |||||||||
Total Shareholders’ Equity | 1,530,169 | 1,468,658 | |||||||||
Total Liabilities and Shareholders’ Equity | $ | 2,019,221 | $ | 1,979,648 |
Three Months Ended | |||||||||||
(in thousands of U.S. dollars, except per share data) | September 29, 2023 |
September 30, 2022 |
|||||||||
Revenues | $ | 685,477 | $ | 655,429 | |||||||
Cost of revenues | (601,073) | (572,673) | |||||||||
Gross profit | 84,404 | 82,756 | |||||||||
Selling, general and administrative expenses | (20,429) | (20,565) | |||||||||
Operating income | 63,975 | 62,191 | |||||||||
Interest income | 5,898 | 1,559 | |||||||||
Interest expense | (45) | (391) | |||||||||
Foreign exchange gain (loss), net | 415 | 2,085 | |||||||||
Other income (expense), net | (80) | (141) | |||||||||
Income before income taxes | 70,163 | 65,303 | |||||||||
Income tax expense | (5,074) | (688) | |||||||||
Net income | 65,089 | 64,615 | |||||||||
Other comprehensive income (loss), net of tax: | |||||||||||
Change in net unrealized gain (loss) on available-for-sale securities | 948 | (1,461) | |||||||||
Change in net unrealized gain (loss) on derivative instruments | (561) | (1,218) | |||||||||
Change in net retirement benefits plan – prior service cost | 126 | 168 | |||||||||
Change in foreign currency translation adjustment | 100 | 246 | |||||||||
Total other comprehensive income (loss), net of tax | 613 | (2,265) | |||||||||
Net comprehensive income | $ | 65,702 | $ | 62,350 | |||||||
Earnings per share | |||||||||||
Basic | $ | 1.80 | $ | 1.77 | |||||||
Diluted | $ | 1.78 | $ | 1.76 | |||||||
Weighted-average number of ordinary shares outstanding (thousands of shares) | |||||||||||
Basic | 36,256 | 36,528 | |||||||||
Diluted | 36,481 | 36,758 |
Three Months Ended | |||||||||||
(in thousands of U.S. dollars) | September 29, 2023 |
September 30, 2022 |
|||||||||
Cash flows from operating activities | |||||||||||
Net income for the period | $ | 65,089 | $ | 64,615 | |||||||
Adjustments to reconcile net income to net cash provided by operating activities | |||||||||||
Depreciation and amortization | 11,961 | 11,055 | |||||||||
(Gain) loss on disposal and impairment of property, plant and equipment and intangibles | 12 | (9) | |||||||||
(Gain) loss from sales and maturities of available-for-sale securities | — | 92 | |||||||||
Amortization of discount (premium) of short-term investments | (596) | 442 | |||||||||
(Reversal of) allowance for doubtful accounts | 803 | (91) | |||||||||
Unrealized loss (gain) on exchange rate and fair value of foreign currency forward contracts | (52) | (386) | |||||||||
Amortization of fair value at hedge inception of interest rate swaps | (88) | (191) | |||||||||
Share-based compensation | 7,733 | 7,723 | |||||||||
Deferred income tax | 1,377 | (219) | |||||||||
Other non-cash expenses | 222 | (439) | |||||||||
Changes in operating assets and liabilities | |||||||||||
Trade accounts receivable | (4,138) | (24,476) | |||||||||
Inventories | 79,481 | 28,808 | |||||||||
Other current assets and non-current assets | 3,238 | (10,661) | |||||||||
Trade accounts payable | (24,397) | (29,774) | |||||||||
Income tax payable | 963 | (276) | |||||||||
Severance liabilities | 706 | 617 | |||||||||
Other current liabilities and non-current liabilities | 2,735 | 13,804 | |||||||||
Net cash provided by operating activities | 145,049 | 60,634 | |||||||||
Cash flows from investing activities | |||||||||||
Purchase of short-term investments | (77,692) | (25,609) | |||||||||
Proceeds from sales of short-term investments | — | 30,000 | |||||||||
Proceeds from maturities of short-term investments | 35,909 | 29,236 | |||||||||
Purchase of property, plant and equipment | (11,435) | (10,258) | |||||||||
Purchase of intangibles | (180) | (11) | |||||||||
Proceeds from disposal of property, plant and equipment | 318 | 9 | |||||||||
Net cash used in investing activities | (53,080) | 23,367 | |||||||||
Cash flows from financing activities | |||||||||||
Repayment of long-term borrowings | (3,047) | (6,094) | |||||||||
Repayment of finance lease liability | — | (2) | |||||||||
Repurchase of ordinary shares | — | (4,900) | |||||||||
Withholding tax related to net share settlement of restricted share units | (12,147) | (16,489) | |||||||||
Net cash used in financing activities | (15,194) | (27,485) | |||||||||
Net increase (decrease) in cash, cash equivalents and restricted cash | $ | 76,775 | $ | 56,516 | |||||||
Movement in cash, cash equivalents and restricted cash | |||||||||||
Cash, cash equivalents and restricted cash at the beginning of period | $ | 231,368 | $ | 198,365 | |||||||
Increase (decrease) in cash, cash equivalents and restricted cash | 76,775 | 56,516 | |||||||||
Effect of exchange rate on cash, cash equivalents and restricted cash | 195 | 520 | |||||||||
Cash, cash equivalents and restricted cash at the end of period | $ | 308,338 | $ | 255,401 | |||||||
Non-cash investing and financing activities | |||||||||||
Construction, software and equipment-related payables | $ | 9,313 | $ | 12,541 |
As of | |||||||||||
(in thousands) | September 29, 2023 |
September 30, 2022 |
|||||||||
Cash and cash equivalents | $ | 308,338 | $ | 255,260 | |||||||
Restricted cash | — | 141 | |||||||||
Cash, cash equivalents and restricted cash | $ | 308,338 | $ | 255,401 |
Three Months Ended | ||||||||||||||||||||||||||
September 29, 2023 |
September 30, 2022 |
|||||||||||||||||||||||||
(in thousands of U.S. dollars, except share data) | Net income | Diluted EPS | Net income | Diluted EPS | ||||||||||||||||||||||
GAAP measures | $ | 65,089 | $ | 1.78 | $ | 64,615 | $ | 1.76 | ||||||||||||||||||
Items reconciling GAAP net income & EPS to non-GAAP net income & EPS: | ||||||||||||||||||||||||||
Related to cost of revenues: | ||||||||||||||||||||||||||
Share-based compensation expenses | 2,165 | 0.06 | 1,915 | 0.05 | ||||||||||||||||||||||
Total related to gross profit | 2,165 | 0.06 | 1,915 | 0.05 | ||||||||||||||||||||||
Related to selling, general and administrative expenses: | ||||||||||||||||||||||||||
Share-based compensation expenses | 5,568 | 0.16 | 5,808 | 0.16 | ||||||||||||||||||||||
Amortization of intangibles | — | — | 83 | 0.00 | ||||||||||||||||||||||
Total related to selling, general and administrative expenses | 5,568 | 0.16 | 5,891 | 0.16 | ||||||||||||||||||||||
Related to other income and expense: | ||||||||||||||||||||||||||
Amortization of deferred debt issuance costs | 8 | 0.00 | 8 | 0.00 | ||||||||||||||||||||||
Total related to other income and expense | 8 | 0.00 | 8 | 0.00 | ||||||||||||||||||||||
Total related to net income & EPS | 7,741 | 0.22 | 7,814 | 0.21 | ||||||||||||||||||||||
Non-GAAP measures | $ | 72,830 | $ | 2.00 | $ | 72,429 | $ | 1.97 | ||||||||||||||||||
Shares used in computing diluted net income per share | ||||||||||||||||||||||||||
GAAP diluted shares | 36,481 | 36,758 | ||||||||||||||||||||||||
Non-GAAP diluted shares | 36,481 | 36,758 |
(in thousands) | Three Months Ended | ||||||||||
September 29, 2023 |
September 30, 2022 |
||||||||||
Net cash provided by operating activities | $ | 145,049 | $ | 60,634 | |||||||
Less: Purchase of property, plant and equipment | (11,435) | (10,258) | |||||||||
Non-GAAP free cash flow | $ | 133,614 | $ | 50,376 |
Diluted
EPS
|
|||||
GAAP net income per diluted share: | $1.78 to $1.85 |
||||
Related to cost of revenues: | |||||
Share-based compensation expenses | 0.05 | ||||
Total related to gross profit | 0.05 | ||||
Related to selling, general and administrative expenses: | |||||
Share-based compensation expenses | 0.15 | ||||
Total related to selling, general and administrative expenses | 0.15 | ||||
Total related to net income & EPS | 0.20 | ||||
Non-GAAP net income per diluted share | $1.98 to $2.05 |